Jazz Pharmaceuticals plc (JAZZ)
NASDAQ: JAZZ · Real-Time Price · USD
230.26
-6.19 (-2.62%)
At close: Nov 20, 2026, 4:00 PM EST
230.62
+0.36 (0.16%)
After-hours: Nov 20, 2026, 7:30 PM EST
Jazz Pharmaceuticals Employees
Jazz Pharmaceuticals had 2,890 employees as of December 31, 2025. The number of employees increased by 90 or 3.21% compared to the previous year. That makes Jazz Pharmaceuticals the 8,180th largest employer in the world and 1,460th in the United States.
Employees
2,890
Change (1Y)
90
Growth (1Y)
3.21%
Revenue / Employee
$1,632,590
Profits / Employee
$71,264
Market Cap
14.78B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 2,890 | 90 | 3.21% |
| Dec 31, 2024 | 2,800 | 0 | - |
| Dec 31, 2023 | 2,800 | 0 | - |
| Dec 31, 2022 | 2,800 | -400 | -12.50% |
| Dec 31, 2021 | 3,200 | 1,260 | 64.95% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| BioNTech SE | 7,807 |
| BioMarin Pharmaceutical | 3,221 |
| Bio-Techne | 3,000 |
| Incyte | 2,844 |
| Alnylam Pharmaceuticals | 2,500 |
| Ascendis Pharma | 1,189 |
| BridgeBio Pharma | 1,085 |
| Exelixis | 1,077 |
JAZZ News
- 4 days ago - Jazz Pharmaceuticals Transcript: Jefferies Global Healthcare Conference - Transcripts
- 8 days ago - Jazz Pharmaceuticals price target raised to $324 from $319 at Morgan Stanley - TheFly
- 9 days ago - Jazz Pharmaceuticals price target raised to $330 from $310 at Piper Sandler - TheFly
- 17 days ago - Jazz Pharmaceuticals to Participate in Upcoming Investor Conferences - PRNewsWire
- 18 days ago - Jazz Pharmaceuticals price target raised to $305 from $296 at RBC Capital - TheFly
- 18 days ago - Jazz Pharmaceuticals price target raised to $310 from $300 at JPMorgan - TheFly
- 18 days ago - Jazz Pharmaceuticals price target raised to $319 from $314 at Morgan Stanley - TheFly
- 18 days ago - Jazz Pharmaceuticals price target raised to $275 from $271 at Barclays - TheFly